163 related articles for article (PubMed ID: 24400548)
1. [Case report; a case of methotrexate-associated lymphoproliferative disorders caused with multiple lung nodules].
Ota H; Koyama N; Nakamura A; Matsuda M; Yamamoto Y; Tomoda K; Yoshikawa M; Kimura H; Enomoto Y; Obayashi C
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2676-8. PubMed ID: 24400548
[No Abstract] [Full Text] [Related]
2. Pulmonary and retroperitoneal lesions induced by methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis.
Yamakawa H; Yoshida M; Katagi H; Hirooka S; Okuda K; Ishikawa T; Takagi M; Kuwano K
Mod Rheumatol; 2016; 26(3):441-4. PubMed ID: 24684409
[TBL] [Abstract][Full Text] [Related]
3. Reversible methotrexate associated lymphoproliferative disease evolving into Hodgkin's disease.
Moseley AC; Lindsley HB; Skikne BS; Tawfik O
J Rheumatol; 2000 Mar; 27(3):810-3. PubMed ID: 10743830
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-related MTX-LPD in rheumatoid arthritis patients exhibits a viral pattern of the CD64 and CD35 expression on neutrophils: three case reports.
Mokuda S; Miyazaki T; Saeki Y; Masumoto J; Kanno M; Takasugi K
Mod Rheumatol; 2015 Jan; 25(1):166-8. PubMed ID: 24499448
[No Abstract] [Full Text] [Related]
5. [Case report; a case suspected that methotrexate-associated lymphoproliferative disorders was developed in the course of therapy of rheumatoid arthritis].
Abe H; Sato Y
Nihon Naika Gakkai Zasshi; 2011 Nov; 100(11):3339-42. PubMed ID: 22250429
[No Abstract] [Full Text] [Related]
6. Endobronchial Manifestation of Methotrexate-induced Lymphoproliferative Disorder.
Ikeue T; Kawachi H; Yoshida H; Tanaka E; Noguchi S; Fukao A; Terashita S; Tajiri T; Horikawa S; Sugita T
Intern Med; 2019 Jun; 58(11):1597-1603. PubMed ID: 30713318
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-associated Lymphoproliferative Disorder with Diffuse Ground-Glass Opacities.
Tsuchiya K; Suzuki Y; Yasui H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Baba S; Suda T
Am J Respir Crit Care Med; 2019 Apr; 199(8):1031-1033. PubMed ID: 30525877
[No Abstract] [Full Text] [Related]
8. Polyradiculopathy due to methotrexate-induced ebv-associated lymphoproliferative disorder.
Kumar N; Sandroni P; Steensma DP; Luthra HS; Habermann TM
Neurology; 2008 Nov; 71(20):1644-5. PubMed ID: 19001256
[No Abstract] [Full Text] [Related]
9. Hepatic methotrexate-associated lymphoproliferative disorders identified by multiple liver tumors: a case report and review of the literature.
Ono R; Kumagae T; Uojima H; Teshima S; Kudo M; Kitagawa I; Yoshizawa M
J Med Case Rep; 2019 Jun; 13(1):196. PubMed ID: 31242930
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate-associated lymphoproliferative disorder with an osteolytic vertebral lesion in an elderly patient with rheumatoid arthritis: A case report.
Hirata C; Kenzaka T; Akita H
J Clin Pharm Ther; 2021 Aug; 46(4):1178-1181. PubMed ID: 33768586
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis presenting in the skin.
Clarke LE; Junkins-Hopkins J; Seykora JT; Adler DJ; Elenitsas R
J Am Acad Dermatol; 2007 Apr; 56(4):686-90. PubMed ID: 17141365
[TBL] [Abstract][Full Text] [Related]
12. Large ulceration of the oropharynx induced by methotrexate-associated lymphoproliferative disorders.
Hanakawa H; Orita Y; Sato Y; Uno K; Nishizaki K; Yoshino T
Acta Med Okayama; 2013; 67(4):265-9. PubMed ID: 23970326
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors.
Kurita D; Miyoshi H; Ichikawa A; Kato K; Imaizumi Y; Seki R; Sato K; Sasaki Y; Kawamoto K; Shimono J; Yamada K; Muto R; Kizaki M; Nagafuji K; Tamaru JI; Tokuhira M; Ohshima K
Am J Surg Pathol; 2019 Jul; 43(7):869-884. PubMed ID: 31116708
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate-associated lymphoproliferative disorder presenting as giant ulcers on the leg.
Oka T; Miyagaki T; Nakamura R; Funamizu K; Sugaya M; Ebisawa K; Koya J; Kurokawa M; Sato S
Clin Exp Dermatol; 2018 Dec; 43(8):930-933. PubMed ID: 29855057
[No Abstract] [Full Text] [Related]
15. Methotrexate-associated lymphoproliferative disorder mimicking pyocyanic ecthyma gangrenosum in a patient with rheumatoid arthritis.
Inuzuka K; Endo Y; Kato M; Fujisawa A; Tanioka M; Kabashima K; Tsukamoto H; Sonobe J; Bessho K; Miyachi Y
Eur J Dermatol; 2013; 23(3):418-9. PubMed ID: 23783770
[No Abstract] [Full Text] [Related]
16. [Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].
Uchida Y; Hokkoku K; Hatanaka Y; Kikuchi Y; Tashiro H; Sonoo M
Rinsho Shinkeigaku; 2018 Aug; 58(8):485-491. PubMed ID: 30068810
[TBL] [Abstract][Full Text] [Related]
17. [A case of methotrexate-associated lymphoproliferative disorder diagnosed by liver biopsy].
Takasumi M; Okai K; Asano T; Kanno Y; Abe K; Takahashi A; Kobayashi H; Hashimoto Y; Watanabe H; Ohira H
Nihon Shokakibyo Gakkai Zasshi; 2015 Jan; 112(1):115-22. PubMed ID: 25744928
[TBL] [Abstract][Full Text] [Related]
18. [Methotrexate-associated lymphoproliferative disorder].
Kaneko Y
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):174-178. PubMed ID: 28747604
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate-associated Lymphoproliferative Disorder: A Rare Differential Diagnosis of Wheezes.
Ujino M; Miyoshi S; Sugimoto N; Arai H; Ota Y; Sasajima Y; Kawamura M; Nagase H; Yamaguchi M; Ohta K
Intern Med; 2019 Jun; 58(12):1759-1764. PubMed ID: 30713294
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report.
Toyonaga H; Fukushima M; Shimeno N; Inokuma T
BMC Gastroenterol; 2019 Apr; 19(1):62. PubMed ID: 31023238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
